HIGH-DOSE CISPLATIN - PHASE-I-II STUDY

被引:0
|
作者
BRUNETTI, I
MERLANO, M
GRIMALDI, A
BENEDETTI, G
GARAVENTA, G
MODENESI, M
ROSSO, R
机构
[1] IST NAZL RIC CANC, Genoa, ITALY
[2] OSPED CIVILI, DIV OTORHINOLARYNGOL, Genoa, ITALY
来源
TUMORI JOURNAL | 1986年 / 72卷 / 06期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:691 / 691
页数:1
相关论文
共 50 条
  • [1] PHASE-I-II STUDY OF HIGH-DOSE ETOPOSIDE IN PATIENTS WITH REFRACTORY BREAST-CANCER
    FRASCHINI, G
    HOLMES, FA
    ESPARZA, L
    THERIAULT, RL
    BUZDAR, AU
    HORTOBAGYI, GN
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (04) : 365 - 367
  • [2] HIGH-DOSE MITOXANTRONE IN METASTATIC BREAST-CANCER - A PHASE-I-II TRIAL
    LEIBY, JM
    UNVERFURTH, DV
    NEIDHART, JA
    CANCER TREATMENT REPORTS, 1986, 70 (07): : 899 - 901
  • [3] PHASE-I STUDY OF HIGH-DOSE CISPLATIN, IFOSFAMIDE, AND ETOPOSIDE
    PEREZ, EA
    SOWRAY, PC
    GARDNER, SL
    GANDARA, DR
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 34 (04) : 331 - 334
  • [4] HIGH-DOSE THIOTEPA AND MITOXANTRONE WITH AUTOLOGOUS STEM-CELL REINFUSION FOR REFRACTORY MALIGNANCIES - A PHASE-I-II STUDY
    FIELDS, KK
    ELFENBEIN, GJ
    HIEMENZ, JW
    ZORSKY, PE
    PACH, LD
    CLINICAL RESEARCH, 1992, 40 (02): : A421 - A421
  • [5] PHASE-I-II STUDY OF HIGH-DOSE EPIRUBICIN IN ADVANCED NON-SMALL-CELL LUNG-CANCER
    FELD, R
    WIERZBICKI, R
    WALDE, PLD
    SHEPHERD, FA
    EVANS, WK
    GUPTA, S
    SHANNON, P
    LASSUS, M
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (02) : 297 - 303
  • [6] A PHASE-I-II TRIAL OF OUTPATIENT HIGH-DOSE INTERLEUKIN-2 (IL-2)
    RICHARDS, JM
    RAMMING, K
    BARKER, E
    VOGELZANG, NJ
    CLINICAL RESEARCH, 1987, 35 (06): : A864 - A864
  • [7] PHASE-I-II TRIAL OF HIGH-DOSE FOSFESTROL IN HORMONE-RESISTANT PROSTATE-CANCER
    KATTAN, J
    DROZ, JP
    CULINE, S
    BULLETIN DU CANCER, 1993, 80 (03) : 248 - 254
  • [8] HIGH-DOSE ADRIAMYCIN - A PHASE I-II STUDY
    WHEELER, RH
    ZUCKERMAN, K
    DABICH, L
    ENSMINGER, WD
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 364 - 364
  • [9] A PHASE-I-II STUDY OF HIGH-DOSE RECOMBINANT HUMAN INTERLEUKIN-2 IN DISSEMINATED RENAL-CELL CARCINOMA
    JAVADPOUR, N
    LALEHZARIAN, M
    SEMINARS IN SURGICAL ONCOLOGY, 1988, 4 (03): : 207 - 209
  • [10] PHASE-II TRIALS OF ONDANSETRON WITH HIGH-DOSE CISPLATIN
    KRIS, MG
    SEMINARS IN ONCOLOGY, 1992, 19 (04) : 23 - 27